Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
These 45 exoplanets may be the best places to search for alien life - 2Solid Propensities: Little Changes for a Superior Life
- 3Figure out How to Assess the Unwavering quality of SUVs for Seniors
- 4Police arrest 18 as anti-war protests spread across Tel Aviv, Haifa, Jerusalem
- 5Director Emerald Fennell explains why "Wuthering Heights" has quotation marks around the title
- How will the universe end?
- Quandoo to shut restaurant booking platform by end of 2026
- Living in the dark: Gaza’s struggle for electricity
- Unsold Rams May Be Less expensive Than You Suspect
- Watch SpaceX launch 119 payloads to orbit from California early on March 30
- Figure out How to Adjust Work, Life, and an Internet based Degree
- Vote In favor of Your Favored Language Learning Applications
- Merz visit highlights new strategic, and strained, Germany-Israel bond
- Israeli military says it hit dozens of military facilities in Tehran
